Literature DB >> 26529369

Why is it appropriate to recommend human papillomavirus vaccination as cervical cancer prevention?

Robert A Bednarczyk1, Daniella Figueroa-Downing2, Kevin Ault3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26529369      PMCID： PMC5689084          DOI： 10.1016/j.ajog.2015.10.920

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  34 in total

1.  HPV vaccination crisis in Japan.

Authors:  Sharon J B Hanley; Eiji Yoshioka; Yoshiya Ito; Reiko Kishi
Journal:  Lancet       Date:  2015-06-27       Impact factor: 79.321

2.  Development and duration of human papillomavirus lesions, after initial infection.

Authors:  Rachel L Winer; Nancy B Kiviat; James P Hughes; Diane E Adam; Shu-Kuang Lee; Jane M Kuypers; Laura A Koutsky
Journal:  J Infect Dis       Date:  2005-01-21       Impact factor: 5.226

3.  Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.

Authors:  Julianne Gee; Allison Naleway; Irene Shui; James Baggs; Ruihua Yin; Rong Li; Martin Kulldorff; Edwin Lewis; Bruce Fireman; Matthew F Daley; Nicola P Klein; Eric S Weintraub
Journal:  Vaccine       Date:  2011-09-09       Impact factor: 3.641

4.  Human papillomavirus vaccine and sexual behavior among adolescent and young women.

Authors:  Nicole C Liddon; Jami S Leichliter; Lauri E Markowitz
Journal:  Am J Prev Med       Date:  2012-01       Impact factor: 5.043

5.  Factors associated with intention to vaccinate a daughter against HPV: a statewide survey in Alabama.

Authors:  Allison G Litton; Renee A Desmond; Janice Gilliland; Warner K Huh; Frank A Franklin
Journal:  J Pediatr Adolesc Gynecol       Date:  2011-03-12       Impact factor: 1.814

6.  HPV vaccine acceptability in a rural Southern area.

Authors:  Karah I Fazekas; Noel T Brewer; Jennifer S Smith
Journal:  J Womens Health (Larchmt)       Date:  2008-05       Impact factor: 2.681

7.  Is human papillomavirus vaccination likely to be a useful strategy in India?

Authors:  Sudeep Gupta; Rajendra A Kerkar; Rajesh Dikshit; Rajendra A Badwe
Journal:  South Asian J Cancer       Date:  2013-10

8.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014.

Authors:  Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-31       Impact factor: 17.586

9.  Cancer screening test use - United States, 2013.

Authors:  Susan A Sabatino; Mary C White; Trevor D Thompson; Carrie N Klabunde
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

10.  Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.

Authors:  Lisen Arnheim-Dahlström; Björn Pasternak; Henrik Svanström; Pär Sparén; Anders Hviid
Journal:  BMJ       Date:  2013-10-09
View more
  1 in total

Review 1.  Addressing HPV vaccine myths: practical information for healthcare providers.

Authors:  Robert A Bednarczyk
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.